Literature DB >> 25777084

Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.

James Watt1, Jennifer J Schlezinger2.   

Abstract

Environmental obesogens are a newly recognized category of endocrine disrupting chemicals that have been implicated in contributing to the rising rates of obesity in the United States. While obesity is typically regarded as an increase in visceral fat, adipocyte accumulation in the bone has been linked to increased fracture risk, lower bone density, and osteoporosis. Exposure to environmental toxicants that activate peroxisome proliferator activated receptor γ (PPARγ), a critical regulator of the balance of differentiation between adipogenesis and osteogenesis, may contribute to the increasing prevalence of osteoporosis. However, induction of adipogenesis and suppression of osteogenesis are separable activities of PPARγ, and ligands may selectively alter these activities. It currently is unknown whether suppression of osteogenesis is a common toxic endpoint of environmental PPARγ ligands. Using a primary mouse bone marrow culture model, we tested the hypothesis that environmental toxicants acting as PPARγ agonists divert the differentiation pathway of bone marrow-derived multipotent mesenchymal stromal cells towards adipogenesis and away from osteogenesis. The toxicants tested included the organotins tributyltin and triphenyltin, a ubiquitous phthalate metabolite (mono-(2-ethylhexyl) phthalate, MEHP), and two brominated flame retardants (tetrabromobisphenol-a, TBBPA, and mono-(2-ethylhexyl) tetrabromophthalate, METBP). All of the compounds activated PPARγ1 and 2. All compounds increased adipogenesis (lipid accumulation, Fabp4 expression) and suppressed osteogenesis (alkaline phosphatase activity, Osx expression) in mouse primary bone marrow cultures, but with different potencies and efficacies. Despite structural dissimilarities, there was a strong negative correlation between efficacies to induce adipogenesis and suppress osteogenesis, with the organotins being distinct in their exceptional ability to suppress osteogenesis. As human exposure to a mixture of toxicants is likely, albeit at low doses, the fact that multiple toxicants are capable of suppressing bone formation supports the hypothesis that environmental PPARγ ligands represent an emerging threat to human bone health.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Mono-(2-ethylhexyl) phthalate; Mono-(2-ethylhexyl) tetrabromophthalate; Organotin; Osteoblast; PPARγ; Tetrabromobisphenol-a

Mesh:

Substances:

Year:  2015        PMID: 25777084      PMCID: PMC4406869          DOI: 10.1016/j.tox.2015.03.006

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  50 in total

1.  Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets.

Authors:  A S Greenberg; J J Egan; S A Wek; N B Garty; E J Blanchette-Mackie; C Londos
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

2.  Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway.

Authors:  Tomohiko Kanayama; Naoki Kobayashi; Satoru Mamiya; Tsuyoshi Nakanishi; Jun-ichi Nishikawa
Journal:  Mol Pharmacol       Date:  2004-12-20       Impact factor: 4.436

3.  Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Authors:  P Ducy; R Zhang; V Geoffroy; A L Ridall; G Karsenty
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

4.  Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways.

Authors:  Elena J Moerman; Kui Teng; David A Lipschitz; Beata Lecka-Czernik
Journal:  Aging Cell       Date:  2004-12       Impact factor: 9.304

5.  Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.

Authors:  B Lecka-Czernik; I Gubrij; E J Moerman; O Kajkenova; D A Lipschitz; S C Manolagas; R L Jilka
Journal:  J Cell Biochem       Date:  1999-09-01       Impact factor: 4.429

6.  Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.

Authors:  Moses T Bility; Jerry T Thompson; Richard H McKee; Raymond M David; John H Butala; John P Vanden Heuvel; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2004-08-13       Impact factor: 4.849

7.  Inhibition of ossification in vivo and differentiation of osteoblasts in vitro by tributyltin.

Authors:  Yu Tsukamoto; Yoko Ishihara; Sachiko Miyagawa-Tomita; Hiromi Hagiwara
Journal:  Biochem Pharmacol       Date:  2004-08-15       Impact factor: 5.858

8.  Bone is a target for the antidiabetic compound rosiglitazone.

Authors:  S O Rzonca; L J Suva; D Gaddy; D C Montague; B Lecka-Czernik
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

9.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

Authors:  P Tontonoz; E Hu; R A Graves; A I Budavari; B M Spiegelman
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

10.  Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.

Authors:  Marthe Moldes; Ying Zuo; Ron F Morrison; David Silva; Bae-Hang Park; Jiajian Liu; Stephen R Farmer
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

View more
  37 in total

1.  Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cells.

Authors:  Amelia H Baker; James Watt; Cassie K Huang; Louis C Gerstenfeld; Jennifer J Schlezinger
Journal:  Chem Res Toxicol       Date:  2015-05-13       Impact factor: 3.739

2.  From the Cover: Tributyltin Alters the Bone Marrow Microenvironment and Suppresses B Cell Development.

Authors:  Amelia H Baker; Ting Hua Wu; Alicia M Bolt; Louis C Gerstenfeld; Koren K Mann; Jennifer J Schlezinger
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

3.  Methylparaben and butylparaben alter multipotent mesenchymal stem cell fates towards adipocyte lineage.

Authors:  Pan Hu; Haley Overby; Emily Heal; Shu Wang; Jiangang Chen; Chwan-Li Shen; Ling Zhao
Journal:  Toxicol Appl Pharmacol       Date:  2017-05-17       Impact factor: 4.219

4.  Tetrabromobisphenol A (TBBPA) Alters ABC Transport at the Blood-Brain Barrier.

Authors:  Ronald E Cannon; Andrew W Trexler; Gabriel A Knudsen; Rebecca A Evans; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

Review 5.  Endocrine disruptors and obesity.

Authors:  Jerrold J Heindel; Retha Newbold; Thaddeus T Schug
Journal:  Nat Rev Endocrinol       Date:  2015-09-22       Impact factor: 43.330

6.  Tributyltin induces a transcriptional response without a brite adipocyte signature in adipocyte models.

Authors:  Stephanie Kim; Amy Li; Stefano Monti; Jennifer J Schlezinger
Journal:  Arch Toxicol       Date:  2018-07-19       Impact factor: 5.153

7.  Differential effects on adiposity and serum marker of bone formation by post-weaning exposure to methylparaben and butylparaben.

Authors:  Pan Hu; Rebekah C Kennedy; Xin Chen; Jia Zhang; Chwan-Li Shen; Jiangang Chen; Ling Zhao
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-18       Impact factor: 4.223

8.  Naringin promotes osteogenic differentiation of bone marrow stromal cells by up-regulating Foxc2 expression via the IHH signaling pathway.

Authors:  Fei-Xiang Lin; Shi-Xin Du; De-Zhong Liu; Qin-Xiao Hu; Guo-Yong Yu; Chu-Cheng Wu; Gui-Zhou Zheng; Da Xie; Xue-Dong Li; Bo Chang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

9.  Tungsten Promotes Sex-Specific Adipogenesis in the Bone by Altering Differentiation of Bone Marrow-Resident Mesenchymal Stromal Cells.

Authors:  Alicia M Bolt; Michael P Grant; Ting Hua Wu; Manuel Flores Molina; Dany Plourde; Alexander D R Kelly; Luis Fernando Negro Silva; Maryse Lemaire; Jennifer J Schlezinger; Fackson Mwale; Koren K Mann
Journal:  Toxicol Sci       Date:  2016-02-09       Impact factor: 4.849

10.  Tributyltin disrupts fin development in Fundulus heteroclitus from both PCB-sensitive and resistant populations: Investigations of potential interactions between AHR and PPARγ.

Authors:  K A Crawford; B W Clark; W J Heiger-Bernays; S I Karchner; M E Hahn; D E Nacci; J J Schlezinger
Journal:  Aquat Toxicol       Date:  2019-11-11       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.